Skip to main content

Table 4 Prognostic factors associated with overall survival based on univariate cox regression models (N = 730)

From: The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis

 

DMFS

LRRFS

PFS

 

OS

B

SE

HR(95%CI)

P

B

SE

HR(95%CI)

P

B

SE

HR(95%CI)

P

B

SE

HR(95%CI)

P

Gender

 Female

 

1

   

1

   

1

   

1

  

 Male

−0.943

0.372

0.389(0.188–0.808)

0.011

0.189

0.280

1.208(0.697–2.092)

0.500

−0.270

0.198

0.764(0.518–1.126)

0.173

−0.570

0.269

0.566(0.3340.959)

0.034

Age

 <44

 

1

   

1

   

1

   

1

  

  ≥ 44

−0.106

0.223

0.900(0.581–1.393)

0.636

− 0.380

0.248

0.684(0.420–1.111)

0.125

− 0.242

0.152

0.785(0.582–1.058)

0.112

− 0.288

0.187

0.750(0.519–1.083)

0.125

Tumor stage

 T1

 

1

   

1

   

1

   

1

  

 T2

0.681

0.486

1.975(0.763–5.116)

0.161

−0.145

0.736

0.865(0.204–3.661)

0.844

0.050

0.396

1.051(0.484–2.285)

0.900

0.050

0.429

1.052 (0.454–2.438)

0.906

 T3

−0.213

0.450

0.808(0.335–1.952)

0.636

0.261

0.408

1.299(0.583–2.891)

0.522

−0.126

0.277

0.882(0.513–1.517)

0.650

−0.584

0.358

0.557 (0.276–1.125)

0.103

 T4

−0.292

0.244

0.747(0.463–1.205)

0.232

−0.373

0.267

0.689(0.408–1.162)

0.162

−0.577

0.162

0.562(0.409–0.772)

0.000

−1.011

0.200

0.364 (0.246–0.538)

0.000

Node stage

 N0

 

1

   

1

   

1

   

1

  

 N1

−1.666

0.466

0.189(0.076–0.471)

0.000

−1.554

0.667

0.211(0.057–0.782)

0.020

−1.443

0.342

0.236(0.121–0.462)

0.000

−1.568

0.406

0.209(0.094–0.463)

0.000

 N2

−1.960

0.325

0.141(0.074–0.267)

0.000

−0.742

0.387

0.476(0.223–1.017)

0.055

−1.216

0.225

0.296(0.191–0.460)

0.000

−1.392

0.258

0.249(0.150–0.412)

0.000

 N3

−1.117

0.278

0.327(0.190–0.564)

0.000

−0.472

0.380

0.624(0.296–1.315)

0.215

−0.832

0.216

0.435(0.285–0.665)

0.000

−1.080

0.249

0.339(0.209–0.553)

0.000

Clinical stage

 III

 

1

   

1

   

1

   

1

  

 IV

−0.606

0.222

0.546(0.353–0.844)

0.006

−0.405

0.244

0.667(0.413–1.076)

0.097

−0.674

0.151

0.510(0.379–0.685)

0.000

−1.166

0.191

0.312(0.214–0.453)

0.000

Target therapy

 Without

 

1

   

1

   

1

   

1

  

 With

0.796

0.325

2.217(1.174–4.188)

0.014

−0.367

0.260

0.693(0.416–1.154)

0.158

0.292

0.187

1.340(0.928–1.933)

0.118

0.707

0.263

2.028(1.213–3.393)

0.007

Induction chemotherapy

 No

 

1

   

1

   

1

   

1

  

 Yes

0.107

0.230

1.113(0.709–1.747)

0.642

−0.354

0.270

0.702(0.413–1.193)

0.191

−0.181

0.163

0.834(0.607–1.148)

0.266

−0.279

0.204

0.756(0.507–1.128)

0.170